MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202511115571 A) filed by Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, on Nov. 22, 2025, for 'mucoadhesive buccal gel formulation for sustained delivery of antihypertensive agents.'
Inventor(s) include Nishant Gaurav; Dr. Sumita Singh; Vishal Kumar Biswkarma; and Dr. Alok Mahor.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The invention discloses a bio-adhesive buccal gel for the delivery of antihypertensive drugs through the buccal mucosa. The gel comprises mucoadhesive polymers (Carbopol, HPMC, sodium alginate, chitosan), permeation enhancers, and plasticizers, forming a flexible and stable formulation. Upon buccal application, the gel adheres to the mucosal lining, enabling prolonged drug retention and controlled release for 6-12 hours. The formulation bypasses hepatic first-pass metabolism, leading to enhanced bioavailability and improved therapeutic efficacy. The invention offers a novel, patient-friendly, and commercially viable drug delivery platform for chronic hypertension management."
Disclaimer: Curated by HT Syndication.
